Glycaemic control improves fibrin network characteristics in type 2 diabetes – A purified fibrinogen model

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH07-11-0699
Issue:2008: 99/4 (Apr) pp. 647-797
Pages:691-700

Glycaemic control improves fibrin network characteristics in type 2 diabetes – A purified fibrinogen model

Marlien Pieters1, Namukolo Covic1, Francois H. van der Westhuizen2, Chandrasekaran Nagaswami3, Yelena Baras3, Du Toit Loots1, Johann C. Jerling1, Dale Elgar4, Kathryn S. Edmondson3, Danie G. van Zyl5, Paul Rheeder6, John W. Weisel3
1Department of Nutrition, North-West University, Potchefstroom, South Africa; 2School of Biochemistry, North-West University, Potchefstroom, South Africa; 3Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 4School of Pharmacy, North-West University, Potchefstroom, South Africa; 5Department of Internal Medicine, University of Pretoria, Pretoria, South Africa; 6Division of Clinical Epidemiology, University of Pretoria, Pretoria, South Africa

Summary

Diabetic subjects have been shown to have altered fibrin network structures.One proposed mechanism for this is non-enzymatic glycation of fibrinogen due to high blood glucose.We investigated whether glycaemic control would result in altered fibrin network structures due to decreased fibrinogen glycation. Twenty uncontrolled type 2 diabetic subjects were treated with insulin in order to achieve glycaemic control. Twenty age- and body mass index (BMI)-matched non-diabetic subjects were included as a reference group. Purified fibrinogen, isolated from plasma samples was used for analysis.There was a significant decrease in fibrinogen glycation (6.81 to 5.02 mol glucose/mol fibrinogen) with a corresponding decrease in rate of lateral aggregation (5.86 to 4.62) and increased permeability (2.45 to 2.85 x 10–8 cm2) and lysis rate (3.08 to 3.27 μm/min) in the diabetic subjects after glycaemic control.These variables correlated with markers of glycaemic control. Fibrin clots of non-diabetic subjects had a significantly higher ratio of inelastic to elastic deformation than the diabetic subjects (0.10 vs. 0.09). Although there was no difference in median fiber diameter between diabetic and non-diabetic subjects, there was a small increase in the proportion of thicker fibers in the diabetic samples after glycaemic control. Results from SDS-PAGE indicated no detectable difference in factor XIIIa-crosslinking of fibrin clots between uncontrolled and controlled diabetic samples. Diabetic subjects may have altered fibrin network formation kinetics which contributes to decreased pore size and lysis rate of fibrin clots. Achievement of glycaemic control and decreased fibrinogen glycation level improves permeability and lysis rates in a purified fibrinogen model.

Keywords

diabetes, fibrin network, fibrinogen glycation, glycaemic control, hyperglycaemia

DOI

http://dx.doi.org/10.1160/TH07-11-0699

You may also be interested in...

1.

H. Stracke

Die Medizinische Welt 2008 59 5: 165-171

2.

M. Schuler

Die Medizinische Welt 2008 59 5: 158-163

3.

O. A. Blanson Henkemans¹, ³, W. A. Rogers², A. D. Fisk², M. A. Neerincx¹, ³, J. Lindenberg³, C. A. P. G. van der Mast1

Methods of Information in Medicine 2008 47 1: 82-87

http://dx.doi.org/10.3414/ME9105



Articles

You've 305 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...